发明名称 Antibiotic compounds
摘要 The present invention relates to carbapenems and provides a compound of the formula (I):or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof wherein:R1 is 1-hydroxyethyl, 1-fluoroethyl or hydroxymethyl;R2 is hydrogen or C1-4alkyl;R3 is hydrogen or C1-4alkyl;R4 and R5 are the same or different and are selected from hydrogen, halo, cyano, C1-4alkyl, nitro, hydroxy, carboxy, C1-4alkoxy, C1-4alkoxycarbonyl, aminosulphonyl, C1-4alkylaminosulphonyl, di-C1-4-alkylaminosulphonyl, carbamoyl, C1-4alkylcarbamoyl, di-C1-4 alkylcarbamoyl, trifluoromethyl, sulphonic acid, amino, C1-4alkylamino, di-C1-4alkylamino, C1-4alkanoylamino, C1-4alkanoyl(N-C1-4alkyl)amino, C1-4alkanesulphonamido and C1-4alkylS(O)n- wherein n is zero; one or two:with the proviso that there is no hydroxy or carboxy substituent in a position ortho to the link to -NR3-. Processes for their preparation, intermediates in their preparation, their use as therapeutic agents and pharmaceutical compositions containing them.
申请公布号 US6521612(B2) 申请公布日期 2003.02.18
申请号 US20010781556 申请日期 2001.02.13
申请人 ZENECA LTD. 发明人 BETTS MICHAEL JOHN;DAVIES GARETH MORSE;SWAIN MICHAEL LINGARD
分类号 A61K31/397;A61K31/40;A61K31/407;A61K31/41;A61K38/40;A61P31/04;C07D205/00;C07D207/00;C07D207/16;C07D403/12;C07D477/00;C07D477/20;C07D487/04;C07F9/568;C07F9/572;C07F9/6574;(IPC1-7):A61K31/553;A61K31/554 主分类号 A61K31/397
代理机构 代理人
主权项
地址